Skip to content

Real world study of butyl phthalide sodium chloride injection in the treatment of acute ischemic stroke

Real world study of butyl phthalide sodium chloride injection in the treatment of acute ischemic stroke

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046094
Enrollment
Unknown
Registered
2021-05-04
Start date
2021-05-06
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

control group:conventional treatment
experimental group:On the basis of conventional treatment, from the onset of the patient within 48 hours to discharge, the patient was given butyl phthalide sodium chloride injection (100ml/bottle), i

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosis of acute ischemic stroke; 2. First onset or previous history of cerebral infarction but the modified Rankin Scale (MRS) score has been restored to 0-1 points; 3. Have clear neurological locational signs, with a National Institutes of Health Stroke Scale (NIHSS) score of 6-25; 4. Aged 18 years or above; 5. Agree to join the study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Intracranial hemorrhagic diseases observed by head CT: hemorrhagic stroke, epidural hematoma, intracranial hematoma, Intraventricular hemorrhage, subarachnoid hemorrhage, etc.; 2. Severe disturbance of consciousness; 3. Bradycardia and sinus syndrome (heart rate 1ULN); 5. Severe bleeding tendency (INR value higher than normal range); 6. Creatinine clearance rate <30ml /min; 7. To celery, research drugs and excipients, control drugs allergy history can not be tolerated; 8. Participated in or is participating in other clinical studies within 3 months prior to the date of informed consent.

Design outcomes

Primary

MeasureTime frame
(NIHSS) National Institutes of Health Neurological Impairment Score;Barthel Index score;Modified Rankin Scale;

Countries

China

Contacts

Public ContactYan Shu

Tianjin Nankai Hospital

NKYYYX@126.com+86 13389989966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026